PALISADE BIO, INC. - PALI

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$381.1M
QoQ value delta ($000)
+$119.4M (+45.65%)
Implied price effect (QoQ)
+18.28%
Shares
Total shares
184,074,779
QoQ shares delta
+34,586,829 (+23.14%)
Total shares held by funds (by quarter)

Market chart (PALI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 124 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Soleus Capital Management, L.P. 27,303 13,063,687 0.94%
B Group, Inc. 23,855 11,414,285 11.2%
AMERIPRISE FINANCIAL INC 23,160 11,081,434 0.0%
Jupiter Topco LLC 22,394 10,689,452 0.01%
BlackRock, Inc. 21,812 10,436,760 0.0%
Octagon Capital Advisors LP 21,477 10,276,317 1.93%
JANUS HENDERSON GROUP PLC 18,759 10,689,452 0.01%
PERCEPTIVE ADVISORS LLC 17,608 8,425,065 0.26%
RA CAPITAL MANAGEMENT, L.P. 14,889 7,124,116 0.13%
FRANKLIN RESOURCES INC 12,091 5,785,189 0.0%
Point72 Asset Management, L.P. 10,979 5,253,403 0.01%
Boxer Capital Management, LLC 10,031 4,799,875 0.76%
ADAGE CAPITAL PARTNERS GP, L.L.C. 9,405 4,500,000 0.01%
Eversept Partners, LP 8,742 4,182,785 0.45%
GEODE CAPITAL MANAGEMENT, LLC 7,861 3,760,485 0.0%
WELLINGTON MANAGEMENT GROUP LLP 7,741 3,703,936 0.0%
GOLDMAN SACHS GROUP INC 7,478 3,578,020 0.0%
FEDERATED HERMES, INC. 6,555 3,136,607 0.01%
Squadron Capital Management LLC 6,270 3,000,000 1.95%
Propel Bio Management, LLC 5,397 2,582,388 2.82%
Vestal Point Capital, LP 5,225 2,500,000 0.12%
STATE STREET CORP 5,174 2,475,648 0.0%
MORGAN STANLEY 5,170 2,474,069 0.0%
ORBIMED ADVISORS LLC 4,875 2,333,000 0.09%
GREAT POINT PARTNERS LLC 4,775 2,284,819 0.9%